The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Potentially inappropriate medication: Association between the use of antidepressant drugs and the subsequent risk for dementia.
Abstract
Background Potentially inappropriate medication (PIM) is associated with an increased risk for detrimental health outcomes in elderly patients. Some antidepressant drugs are considered as PIM, but previous research on the association between antidepressants and subsequent dementia has been inconclusive. Therefore, we investigated whether the intake of antidepressants, particularly of those considered as PIM according to the Priscus list, would predict incident dementia. Methods We used data of a prospective cohort study of non-demented primary care patients (n = 3239, mean age = 79.62) to compute Cox proportional hazards models. The risk for subsequent dementia was estimated over eight follow-ups up to 12 years depending on antidepressant intake and covariates. Results The intake of antidepressants was associated with an increased risk for subsequent dementia (HR = 1.53, 95% CI: 1.16-2.02, p = .003; age-, sex-, education-adjusted). PIM antidepressants (HR = 1.49, 95% CI: 1.06-2.10, p = .021), but not other antidepressants (HR = 1.04, 95% CI: 0.66-1.66, p = .863), were associated with an increased risk for subsequent dementia (in age-, sex-, education-, and depressive symptoms adjusted models). Significant associations disappeared after global cognition at baseline was controlled for. Limitations Methodological limitations such as selection biases and self-reported drug assessments might have influenced the results. Conclusions Only antidepressants considered as PIM were assoc…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Prior cohort studies on antidepressant use and dementia risk have produced contrasting results.
“Long-term observational data are needed, but cohort studies to date have produced contrasting results. While various studies observed increased risk of dementia in antidepressant users, 4,8-14 several others did not. 15-19”
From Antidepressant use in relation to dementia risk, cognitive decline, and brain atrophy (2024) · cites this paper as [12]
Other studies did link antidepressant use to increased dementia risk.
“In contrast, other studies did link antidepressant use to increased dementia risk. 4,8-14”
From Antidepressant use in relation to dementia risk, cognitive decline, and brain atrophy (2024) · cites this paper as [12]
Citations
Cites
Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study
Gray, S. L., Anderson, M. L., Dublin, S., Hanlon, J. T., Hubbard, R., Walker, R., Yu, O., Crane, P. K., & Larson, E. B. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7663 · Cited by 1,111
Kessing, L. V., Søndergård, L., Forman, J. L., & Andersen, P. K. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.020 · Cited by 113
Antidepressant Treatment and Risk of Dementia: A Population-Based, Retrospective Case-Control Study
Lee, C. W.-S., Lin, C.-L., Sung, F.-C., Liang, J.-A., & Kao, C.-H. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09580 · Cited by 61
Flagged first, then by citations
Research works printed but not linked: 32
- Amann, 2012, Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list, Dtsch. Artzebl. Int., 109, 69
- Bali, 2016, Comparative effectiveness of second-generation antidepressants in reducing the risk of dementia in elderly nursing home residents with depression, Pharmacotherapy, 36, 38, 10.1002/phar.1680 · DOI · Paper page
- Blessed, 1968, The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects, Br. J. Psychiatry, 114, 797, 10.1192/bjp.114.512.797 · DOI · Paper page
- Caraci, 2010, Depression and Alzheimer´s disease: neurobiological links and common pharmacological targets, Eur. J. Pharmacol., 626, 64, 10.1016/j.ejphar.2009.10.022 · DOI
- Carrière, 2009, Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study, Arch. Intern. Med., 169, 1317, 10.1001/archinternmed.2009.229 · DOI · Paper page
- Diniz, 2013, Late-life depression and risk of vascular dementia and Alzheimer´s disease: systematic review and meta-analysis of community-based cohort studies, Br. J. Psychiatry, 202, 329, 10.1192/bjp.bp.112.118307 · DOI · Paper page
- Dranovsky, 2006, Hippocampal neurogenesis: regulation by stress and antidepressants, Biol. Psychiatry, 59, 1136, 10.1016/j.biopsych.2006.03.082 · DOI · Paper page
- Folstein, 1975, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- Fuhrer, 2003, Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study, J. Am. Geriatr. Soc., 51, 1055, 10.1046/j.1532-5415.2003.51352.x · DOI
- Gauggel, 1999, Validity and reliability of a German version of the Geriatric depression scale (GDS), Z. Klin. Psychol. Forsch. Prax., 28, 18, 10.1026//0084-5345.28.1.18 · DOI
- Geerlings, 2012, Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia, J. Alzheimers Dis., 30, 75, 10.3233/JAD-2012-112009 · DOI
- Heser, 2013, Age of major depression onset, depressive symptoms, and risk for subsequent dementia: results of the German study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe), Psychol. Med., 43, 1597, 10.1017/S0033291712002449 · DOI
- Holt, 2010, Potentially inappropriate medications in the elderly: the PRISCUS list, Dtsch. Arztebl. Int., 107, 543
- Jessen, 2010, Anticholinergic drug use and risk for dementia: target for dementia prevention, Eur. Arch. Psychiatry Clin. Neurosci., 260, S111, 10.1007/s00406-010-0156-4 · DOI · Paper page
- Jobski, 2017, Characteristics and drug use patterns of older antidepressant initiators in Germany, Eur. J. Clin. Pharmacol., 73, 105, 10.1007/s00228-016-2145-7 · DOI
- Kaup, 2016, Trajectories of depressive symtpoms in older adults and risk of dementia, JAMA Psychiatry, 73, 525, 10.1001/jamapsychiatry.2016.0004 · DOI · Paper page
- Lau, 2005, Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents, Arch. Intern. Med., 165, 68, 10.1001/archinte.165.1.68 · DOI
- Leydon, 2007, A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors, Fam. Pract., 24, 570, 10.1093/fampra/cmm069 · DOI · Paper page
- Li, 2011, Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study, Arch. Gen. Psychiatry, 68, 970, 10.1001/archgenpsychiatry.2011.86 · DOI
- Mulsant, 2014, A systematic approach to pharmacotherapy for geriatric major depression, Clin. Geriatr. Med., 30, 517, 10.1016/j.cger.2014.05.002 · DOI
- Ownby, 2006, Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis, Arch. Gen. Psychiatry, 63, 530, 10.1001/archpsyc.63.5.530 · DOI · Paper page
- Papenberg, 2017, Anticholinergic drug use is associated with episodic memory decline in older adults without dementia, Neurobiol. Aging, 55, 27, 10.1016/j.neurobiolaging.2017.03.009 · DOI
- Pohontsch, 2017, General practitioners´ views on (long-term) prescription and use of problematic and potentially inappropriate medication for oldest-old patients – a qualitative interview study with GPs (CIM-TRIAD study), BMC Fam. Pract., 18, 22, 10.1186/s12875-017-0595-3 · DOI
- Reisberg, 1982, The Global deterioration scale for assessment of primary degenerative dementia, Am. J. Psychiatry, 139, 1136, 10.1176/ajp.139.9.1136 · DOI
- Risacher, 2016, Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults, JAMA Neurol., 73, 721, 10.1001/jamaneurol.2016.0580 · DOI · Paper page
- Román, 1993, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250 · DOI · Paper page
- Saczynski, 2015, Antidepressant use and cognitive decline: the health and retirement study, Am. J. Med., 128, 739, 10.1016/j.amjmed.2015.01.007 · DOI · Paper page
- Schneeweiss, 2002, Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study, Eur. J. Clin. Pharmacol., 58, 285, 10.1007/s00228-002-0467-0 · DOI
- Verbeek-Heida, 2006, Better safe than sorry – why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study, Chronic Illn., 2, 133
- Wang, 2016, Antidepressant use in the elderly is associated with an increased risk of dementia, Alzheimer Dis. Assoc. Disord., 30, 99, 10.1097/WAD.0000000000000103 · DOI · Paper page
- Wucherer, 2017, Potentially inappropriate medication in community-dwelling primary care patients who were screened positive for dementia, J. Alzheimers Dis., 55, 691, 10.3233/JAD-160581 · DOI
- Zimmermann, 2013, Potentially inappropriate medication in elderly primary care patients: a retrospective, longitudinal analysis, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 56, 941, 10.1007/s00103-013-1767-5 · DOI
Cited by
Sorted by citations
Chan, J. Y. C., Yiu, K. K. L., Kwok, T. C. Y., Wong, S. Y. S., & Tsoi, K. K. F. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.12.004 · Cited by 135
Exposure to Antidepressant Medication and the Risk of Incident Dementia
Kodesh, A., Sandin, S., Reichenberg, A., Rotstein, A., Pedersen, N. L., Ericsson, M., Karlsson, I. K., Davidson, M., & Levine, S. Z. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.05.019 · Cited by 63
Antidepressant use in relation to dementia risk, cognitive decline, and brain atrophy
vom Hofe, I., Stricker, B. H., Vernooij, M. W., Ikram, M. K., Ikram, M. A., & Wolters, F. J. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13807 · Cited by 24
Wang, G. H.-M., Li, P., Wang, Y., Guo, J., Wilson, D. L., & Lo-Ciganic, W.-H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196342 · Cited by 23
Risk of dementia among antidepressant elderly users: A population-based cohort analysis in Spain
Santandreu, J., Caballero, F. F., Gómez-Serranillos, M. P., & González-Burgos, E. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.002 · Cited by 3
Metadata
- Authors
- Heser, K., Luck, T., Röhr, S., Wiese, B., Kaduszkiewicz, H., Oey, A., Bickel, H., Mösch, E., Weyerer, S., Werle, J., Brettschneider, C., König, H.-H., Fuchs, A., Pentzek, M., van den Bussche, H., Scherer, M., Maier, W., Riedel-Heller, S. G., & Wagner, M.
- Affiliations
- University of Bonn (DE)
- Leipzig University (DE)
- Medizinische Hochschule Hannover (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Technical University of Munich (DE)
- Heidelberg University (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Heser, Kathrin
- ORCID
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 226
- Pages
- 28-35
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2755554653
- Cited by
- 38
- References
- 3
- Citations by year
- 2025: 5 · 2024: 9 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 7 · 2019: 4 · 2018: 5
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- German Federal Ministry of Education and Research (01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433, 01GI0434)
- KNDD (01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, 01GI0716)
- Health Service Research Initiative (01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, 01GY1322G)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- potentially inappropriate medications, antidepressants, dementia risk, PRISCUS list, elderly patients, anticholinergic effects, cognitive function, depression, primary care patients
- MeSH terms
- Potentially Inappropriate Medication List, Aged, Aged, 80 and over, Antidepressive Agents, Cognition, Dementia, Depression, Female, Humans, Male, Primary Health Care, Prospective Studies, Risk Factors, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review